APA

Campiotti L., Suter M. B., Guasti L., Piazza R., Gambacorti-Passerini C., Grandi A. M. & Squizzato A. (20170814). Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. : European journal of cancer (Oxford, England : 1990).

Chicago

Campiotti Leonardo, Suter Matteo Basilio, Guasti Luigina, Piazza Rocco, Gambacorti-Passerini Carlo, Grandi Anna Maria and Squizzato Alessandro. 20170814. Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. : European journal of cancer (Oxford, England : 1990).

Harvard

Campiotti L., Suter M. B., Guasti L., Piazza R., Gambacorti-Passerini C., Grandi A. M. and Squizzato A. (20170814). Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. : European journal of cancer (Oxford, England : 1990).

MLA

Campiotti Leonardo, Suter Matteo Basilio, Guasti Luigina, Piazza Rocco, Gambacorti-Passerini Carlo, Grandi Anna Maria and Squizzato Alessandro. Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. : European journal of cancer (Oxford, England : 1990). 20170814.